Koen Dewaele

Koen Dewaele

Koen Dewaele

CEO - ADx NeuroSciences

Koen Dewaele holds a MSc degree in Biology from the University of Ghent. He has more than 30 years of experience in medical diagnostics in different In Vitro Diagnostic companies.

He worked for Innogenetics from 1999 till 2011 where he held several positions but could excel most when leading the pioneering Alzheimer program as a director. He has a good understanding of the market needs, opportunities, the business and the science which helps him to decide on the best strategy forward.

In 2011, Koen left Innogenetics to co-found with 3 other colleagues and the University of Leuven ADx NeuroSciences. Koen leads as CEO the company which focuses on the development of novel markers for use in neurodegenerative diseases as tools for advancing drug development or as diagnostic tools in clinical practice. He is convinced that the R&D collaborations of ADx NeuroSciences with academic centers, pharmaceutical and diagnostic companies will contribute to finding a solution for devastating neurodegenerative illnesses like Alzheimer’s and Parkinson’s disease.  

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners